Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock The Manila Times
Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock The Manila Times
Summary aggregated from The Manila Times's public RSS feed. The full reporting belongs to The Manila Times — please read it on their site.